Yuen M-F, Tanaka Y, Ng I O-L, Mizokami M, Yuen J C-H, Wong D K-H, Yuan H-J, Sum S-M, Chan A O-O, Lai C-L
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
J Viral Hepat. 2005 Sep;12(5):513-8. doi: 10.1111/j.1365-2893.2005.00629.x.
The role of infection with hepatitis B virus (HBV) genotypes on liver histology is largely unknown. The aim of study was to investigate the relationships between HBV genotypes (B, C), core-promoter (CP) and precore mutants and liver histology in 66 patients. Liver biopsies were scored by histologic activity index (HAI). HBV genotypes were determined by enzyme-linked immunosorbent assay (ELISA). Eighteen (27.3%) and 48 patients (72.7%) had genotype B (all were subtype Ba) and C, respectively. Forty-seven (71.2%) and 27 (40.9%) had CP and precore mutations, respectively. Patients with genotype C compared with subtype Ba had higher median scores of HAI-necroinflammation (HAI-NI) (7 vs 3), HAI-fibrosis (HAI-F) (1 vs 0) and total HAI (8.5 vs 3) (all P < 0.03). Patients with CP mutations compared with wild-type had higher median scores of HAI-NI (7 vs 3), HAI-F (3 vs 0) and total HAI (9 vs 3) (all P < 0.03). Forty patients (83.5%) with genotype C had CP mutations. Age and alanine aminotransferase levels were positively correlated with HAI scores while albumin levels were negatively correlated (P < 0.01 for all, except albumin levels and HAI-F, P = 0.08). There was no association between precore mutations and HAI scores. Multivariate analysis indicated that higher alanine aminotransferase (ALT) levels were associated with higher HAI scores (P < 0.04) and CP mutations were associated with higher HAI-NI (P = 0.034), but not with HAI-F score (P = 0.3). CP mutations were associated with more severe necroinflammation. The association between genotype C and poor histology was probably because of the association between genotype C and CP mutations.
乙型肝炎病毒(HBV)基因型感染对肝脏组织学的作用在很大程度上尚不清楚。本研究的目的是调查66例患者中HBV基因型(B、C)、核心启动子(CP)和前核心突变与肝脏组织学之间的关系。肝活检采用组织学活动指数(HAI)评分。通过酶联免疫吸附测定(ELISA)确定HBV基因型。分别有18例(27.3%)和48例(72.7%)患者为B基因型(均为Ba亚型)和C基因型。分别有47例(71.2%)和27例(40.9%)存在CP和前核心突变。与Ba亚型相比,C基因型患者的HAI-坏死炎症(HAI-NI)(7对3)、HAI-纤维化(HAI-F)(1对0)和总HAI(8.5对3)的中位数得分更高(所有P<0.03)。与野生型相比,CP突变患者的HAI-NI(7对3)、HAI-F(3对0)和总HAI(9对3)的中位数得分更高(所有P<0.03)。40例(83.5%)C基因型患者存在CP突变。年龄和丙氨酸转氨酶水平与HAI评分呈正相关,而白蛋白水平与HAI评分呈负相关(除白蛋白水平与HAI-F外,所有P<0.01,白蛋白水平与HAI-F,P=0.08)。前核心突变与HAI评分之间无关联。多变量分析表明,较高的丙氨酸转氨酶(ALT)水平与较高的HAI评分相关(P<0.04),CP突变与较高的HAI-NI相关(P=0.034),但与HAI-F评分无关(P=0.3)。CP突变与更严重的坏死炎症相关。C基因型与不良组织学之间的关联可能是由于C基因型与CP突变之间的关联。